Amgen Inc.

Informe acción NasdaqGS:AMGN

Capitalización de mercado: US$144.5b

Salud financiera de hoja de balance de Amgen

Salud financiera controles de criterios 1/6

Amgen tiene un patrimonio de accionistas total de $6.2B y una deuda total de $64.6B, lo que sitúa su ratio deuda-patrimonio en 1036.8%. Sus activos y pasivos totales son $97.2B y $90.9B respectivamente. El BAIT de Amgen es de $8.2B, por lo que su ratio de cobertura de intereses es de 2.8. Tiene efectivo e inversiones a corto plazo que ascienden a $10.9B.

Información clave

1,036.8%

Ratio deuda-patrimonio

US$64.61b

Deuda

Ratio de cobertura de intereses2.8x
EfectivoUS$10.94b
PatrimonioUS$6.23b
Total pasivoUS$90.92b
Activos totalesUS$97.15b

Actualizaciones recientes sobre salud financiera

Recent updates

Amgen: The Giant With An Impressive Pipeline

Apr 15

Is Amgen (NASDAQ:AMGN) Using Too Much Debt?

Apr 01
Is Amgen (NASDAQ:AMGN) Using Too Much Debt?

Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock

Mar 31

Amgen Will Benefit From Increased Medical Spending

Mar 12

Amgen: A Good Dividend Growth Stock For The Watch List

Mar 04

Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit

Feb 21
Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit

Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now

Feb 16
Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now

Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable

Feb 08

Amgen: Accelerating The Business And Dividend Growth

Jan 29

Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?

Jan 29
Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?

Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks

Jan 22

Is Amgen (NASDAQ:AMGN) A Risky Investment?

Dec 28
Is Amgen (NASDAQ:AMGN) A Risky Investment?

Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors

Dec 13
Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors

Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 46%?

Oct 23
Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 46%?

Is Amgen (NASDAQ:AMGN) Using Too Much Debt?

Sep 22
Is Amgen (NASDAQ:AMGN) Using Too Much Debt?

Do Amgen's (NASDAQ:AMGN) Earnings Warrant Your Attention?

Sep 04
Do Amgen's (NASDAQ:AMGN) Earnings Warrant Your Attention?

Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13

Aug 05
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13

Amgen Inc. (NASDAQ:AMGN) Shares Could Be 45% Below Their Intrinsic Value Estimate

May 30
Amgen Inc. (NASDAQ:AMGN) Shares Could Be 45% Below Their Intrinsic Value Estimate

Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year

May 09
Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year

These 4 Measures Indicate That Amgen (NASDAQ:AMGN) Is Using Debt Reasonably Well

Apr 29
These 4 Measures Indicate That Amgen (NASDAQ:AMGN) Is Using Debt Reasonably Well

Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13

Apr 05
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13

Amgen Inc. (NASDAQ:AMGN) Shares Could Be 37% Below Their Intrinsic Value Estimate

Feb 27
Amgen Inc. (NASDAQ:AMGN) Shares Could Be 37% Below Their Intrinsic Value Estimate

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($30.3B) de AMGN superan a sus pasivos a corto plazo ($18.4B).

Pasivo a largo plazo: Los activos a corto plazo ($30.3B) de AMGN no cubren sus pasivos a largo plazo ($72.5B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de AMGN (861.2%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de AMGN ha crecido de 271.4% a 1036.8% en los últimos 5 años.

Cobertura de la deuda: La deuda de AMGN no está bien cubierta por el flujo de caja operativo (13.1%).

Cobertura de intereses: Los pagos de intereses de la deuda de AMGN no están bien cubiertos por el BAIT (2.8x cobertura).


Hoja de balance


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target